{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:28:31Z","timestamp":1785094111405,"version":"3.55.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6460,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1093\/annonc\/mdf125","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:59:57Z","timestamp":1027724397000},"page":"669-678","source":"Crossref","is-referenced-by-count":120,"title":["Cyclooxygenase-2 (COX-2), aromatase and breast cancer:a possible role for COX-2 inhibitors in breast cancer chemoprevention"],"prefix":"10.1016","volume":"13","author":[{"given":"G.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dowsett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdf125_bb0010","first-page":"593","article-title":"Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol","volume":"11","author":"Mehta","year":"1991","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","article-title":"Aspirin use and reduced risk of fatal colon cancer","volume":"325","author":"Thun","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf125_bb0020","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/jnci\/85.11.912","article-title":"Reduced risk of large-bowel adenomas among aspirin users","volume":"85","author":"Greenberg","year":"1993","journal-title":"The Polyp Prevention Study Group. J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/bmj.307.6899.285","article-title":"Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme","volume":"307","author":"Logan","year":"1993","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdf125_bb0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/1097-0142(19930815)72:4<1171::AID-CNCR2820720407>3.0.CO;2-D","article-title":"Aspirin use, cancer, and polyps of the large bowel","volume":"72","author":"Suh","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0035","first-page":"955","article-title":"Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women","volume":"5","author":"Reeves","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdf125_bb0040","first-page":"2556","article-title":"Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis","volume":"56","author":"Boolbol","year":"1996","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0045","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/gast.1996.v110.pm8613017","article-title":"Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors","volume":"110","author":"DuBois","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdf125_bb0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0016-5085(96)70083-5","article-title":"Elevated cyclooxygenase-2 levels in Min mouse adenomas","volume":"111","author":"Williams","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdf125_bb0055","first-page":"3465","article-title":"Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis","volume":"57","author":"Singh","year":"1997","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0060","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1093\/annonc\/mdf125_bb0065","first-page":"2556","article-title":"Expression of prostaglandin G\/H synthase-1 and -2 protein in human colon cancer","volume":"55","author":"Kargman","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0070","first-page":"3785","article-title":"Expression of cyclooxygenase-1 and -2 in human colorectal cancer","volume":"55","author":"Sano","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0075","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1073\/pnas.93.10.4816","article-title":"Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect","volume":"93","author":"Kutchera","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdf125_bb0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/83.5.355","article-title":"A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer","volume":"83","author":"Rosenberg","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"key":"10.1093\/annonc\/mdf125_bb0090","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/bjs.1800801244","article-title":"Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis","volume":"80","author":"Nugent","year":"1993","journal-title":"Br J Surg"},{"key":"10.1093\/annonc\/mdf125_bb0095","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf125_bb0100","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/jnci\/88.14.988","article-title":"Prospective study of regular aspirin use and the risk of breast cancer","volume":"88","author":"Egan","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"key":"10.1093\/annonc\/mdf125_bb0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1093\/annonc\/mdf125_bb0115","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0021-9258(17)33534-2","article-title":"Purification of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes","volume":"251","author":"Miyamoto","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0120","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1073\/pnas.88.7.2692","article-title":"Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing","volume":"88","author":"Xie","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdf125_bb0125","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0130","first-page":"5575","article-title":"Aspirin and the potential role of prostaglandins in colon cancer","volume":"52","author":"Marnett","year":"1992","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0005-2760(95)00194-8","article-title":"Prostaglandin synthase 2","volume":"1299","author":"Herschman","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/annonc\/mdf125_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-2143(96)90023-2","article-title":"Cyclooxygenase-2 induction: molecular mechanism and pathophysiologic roles","volume":"128","author":"Wu","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1093\/annonc\/mdf125_bb0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-8674(00)81664-5","article-title":"PPAR\u0394 is an APC-regulated target of nonsteroidal anti-inflammatory drugs","volume":"99","author":"He","year":"1999","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdf125_bb0150","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1101\/gad.13.12.1561","article-title":"Cyclooxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR\u0394","volume":"13","author":"Lim","year":"1999","journal-title":"Genes Dev"},{"key":"10.1093\/annonc\/mdf125_bb0155","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1074\/jbc.M005077200","article-title":"Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage\/monocytic cells","volume":"276","author":"Mestre","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0160","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.1074\/jbc.273.49.32943","article-title":"Ceramide regulates the transcription of cyclooxygenase-2. Evidence for involvement of extracellular signal-regulated kinase\/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways","volume":"273","author":"Subbaramaiah","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1124\/mol.59.3.493","article-title":"Tumor necrosis factor-\u03b1-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and I\u03baB kinase 1\/2 in human alveolar epithelial cells","volume":"59","author":"Chen","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1093\/annonc\/mdf125_bb0170","first-page":"267","article-title":"The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines","volume":"15","author":"Gilhooly","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1093\/annonc\/mdf125_bb0175","first-page":"131","article-title":"Strong association between c-myb and oestrogen-receptor expression in human breast cancer","volume":"5","author":"Guerin","year":"1990","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdf125_bb0180","first-page":"723","article-title":"Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa","volume":"3","author":"Ramsay","year":"1992","journal-title":"Cell Growth Differ"},{"key":"10.1093\/annonc\/mdf125_bb0185","first-page":"1805","article-title":"Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB","volume":"60","author":"Ramsay","year":"2000","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0190","first-page":"503","article-title":"Cyclooxygenase-2 gene expression in human breast cancer","volume":"10","author":"Parrett","year":"1997","journal-title":"Int J Oncol"},{"key":"10.1093\/annonc\/mdf125_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"key":"10.1093\/annonc\/mdf125_bb0200","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jjco\/28.7.421","article-title":"Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps","volume":"28","author":"Maekawa","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"10.1093\/annonc\/mdf125_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.2296722","article-title":"A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse","volume":"247","author":"Moser","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/mdf125_bb0210","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1073\/pnas.92.10.4482","article-title":"Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene","volume":"92","author":"Oshima","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdf125_bb0215","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc\u0394 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2)","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1093\/annonc\/mdf125_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0304-3835(99)00050-6","article-title":"Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens","volume":"140","author":"Brueggemeier","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1093\/annonc\/mdf125_bb0225","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer","volume":"90","author":"Hwang","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0230","article-title":"Increased expression of cyclooxygenase-2 in HER-2-overexpressing human breast cancer cells","author":"Subbaramaiah","year":"1999","journal-title":"NCI 7th SPORE Investigators Workshop"},{"key":"10.1093\/annonc\/mdf125_bb0235","first-page":"451P","article-title":"Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers","volume":"66","author":"Bennett","year":"1979","journal-title":"Br J Pharmacol"},{"key":"10.1093\/annonc\/mdf125_bb0240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0163-7827(86)90109-8","article-title":"The production of prostanoids in human cancers, and their implications for tumor progression","volume":"25","author":"Bennett","year":"1986","journal-title":"Prog Lipid Res"},{"key":"10.1093\/annonc\/mdf125_bb0245","first-page":"1061","article-title":"Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells","volume":"64","author":"Rolland","year":"1980","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0250","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/bjc.1995.523","article-title":"Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators","volume":"72","author":"Schrey","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0255","first-page":"4779","article-title":"Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas","volume":"45","author":"Fulton","year":"1985","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0260","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3835(97)00387-X","article-title":"Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas","volume":"122","author":"Robertson","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1093\/annonc\/mdf125_bb0265","first-page":"3031","article-title":"Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas","volume":"19","author":"Alshafie","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0270","first-page":"1803","article-title":"Modulation of rat mammary carcinogenesis by indomethacin","volume":"45","author":"McCormick","year":"1985","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0275","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase-2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0280","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1349-7006.2000.tb01030.x","article-title":"Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats","volume":"91","author":"Nakatsugi","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0285","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice","volume":"276","author":"Liu","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0290","first-page":"5125","article-title":"Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines","volume":"56","author":"Liu","year":"1996","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0295","first-page":"1306","article-title":"Antiangiogenic and antitumour activities of cyclooxygenase-2 inhibitors","volume":"60","author":"Masferrer","year":"2000","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0300","first-page":"991","article-title":"Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck","volume":"59","author":"Chan","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0305","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.neo.7900127","article-title":"Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis","volume":"3","author":"Gallo","year":"2001","journal-title":"Neoplasia"},{"key":"10.1093\/annonc\/mdf125_bb0315","first-page":"135","article-title":"Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer","volume":"6","author":"Uefuji","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0320","first-page":"4574","article-title":"Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis","volume":"59","author":"Daniel","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0325","first-page":"4739","article-title":"Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small-cell lung carcinoma","volume":"6","author":"Marrogi","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0330","first-page":"1325","article-title":"Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases","volume":"7","author":"Rahman","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0335","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm0901-1041","article-title":"NSAIDs inhibit \u03b1V\u03b23 integrin-mediated and Cdc42\/Rac-dependent endothelial-cell spreading, migration and angiogenesis","volume":"7","author":"Dormond","year":"2001","journal-title":"Nature Med"},{"key":"10.1093\/annonc\/mdf125_bb0340","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0345","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng","year":"1998","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdf125_bb0350","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1093\/annonc\/mdf125_bb0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","article-title":"The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer","volume":"24","author":"Key","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1093\/annonc\/mdf125_bb0360","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.1997.398","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey","volume":"76","author":"Thomas","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0365","first-page":"79","article-title":"A prospective study of endogenous hormones and breast cancer","volume":"18","author":"Helzlsouer","year":"1994","journal-title":"Cancer Detect Prev"},{"key":"10.1093\/annonc\/mdf125_bb0370","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/jnci\/87.3.190","article-title":"A prospective study of endogenous estrogens and breast cancer in postmenopausal women","volume":"87","author":"Toniolo","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/88.5.291","article-title":"Serum sex hormone levels after menopause and subsequent breast cancer","volume":"88","author":"Berrino","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdf125_bb0380","first-page":"533","article-title":"Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk","volume":"5","author":"Dorgan","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdf125_bb0385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.2910440208","article-title":"In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione","volume":"44","author":"Reed","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.1976.13","article-title":"Oestradiol synthesis from C19 steroids by human breast cancers","volume":"33","author":"Miller","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0395","first-page":"337","article-title":"Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation","volume":"140","author":"Esteban","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/mdf125_bb0400","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0046-8177(94)90127-9","article-title":"Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders","volume":"25","author":"Sasano","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1093\/annonc\/mdf125_bb0405","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1210\/endo.137.7.8770932","article-title":"Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers","volume":"137","author":"Lu","year":"1996","journal-title":"Endocrinology"},{"key":"10.1093\/annonc\/mdf125_bb0410","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.296.6624.741","article-title":"Aromatase activity in adipose tissue from breast quadrants: a link with tumour site","volume":"296","author":"O\u2019Neill","year":"1988","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdf125_bb0415","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0039-128X(87)90037-7","article-title":"The importance of local synthesis of estrogen within the breast","volume":"50","author":"Miller","year":"1987","journal-title":"Steroids"},{"key":"10.1093\/annonc\/mdf125_bb0420","first-page":"1622","article-title":"link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription","volume":"77","author":"Bulun","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdf125_bb0425","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0960-0760(95)00231-6","article-title":"The control and biological importance of intratumoural aromatase in breast cancer","volume":"56","author":"Dowsett","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1093\/annonc\/mdf125_bb0430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0960-0760(96)00100-8","article-title":"Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription\u2013polymerase chain reaction","volume":"59","author":"Zhou","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1093\/annonc\/mdf125_bb0435","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0006-291X(92)92303-F","article-title":"A unique aromatase (P-450arom) mRNA formed by alternative use of tissue-specific exons I in human skin fibroblasts","volume":"189","author":"Harada","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/annonc\/mdf125_bb0440","doi-asserted-by":"crossref","first-page":"19463","DOI":"10.1016\/S0021-9258(19)36538-X","article-title":"Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue","volume":"268","author":"Mahendroo","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0445","first-page":"340","article-title":"Characterization of the sequences of the human CYP19(aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes","volume":"9","author":"Zhao","year":"1995","journal-title":"Mol Endocrinol"},{"key":"10.1093\/annonc\/mdf125_bb0450","doi-asserted-by":"crossref","first-page":"13561","DOI":"10.1074\/jbc.270.22.13561","article-title":"Ad4BP\/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary","volume":"270","author":"Michael","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdf125_bb0455","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(97)00178-0","article-title":"A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene","volume":"134","author":"Michael","year":"1997","journal-title":"Mol Cell Endocrinol"},{"key":"10.1093\/annonc\/mdf125_bb0460","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/endo.137.12.8940410","article-title":"Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene","volume":"137","author":"Zhao","year":"1996","journal-title":"Endocrinology"},{"key":"10.1093\/annonc\/mdf125_bb0465","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.132R005","article-title":"Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells","volume":"132","author":"Reed","year":"1992","journal-title":"J Endocrinol"},{"key":"10.1093\/annonc\/mdf125_bb0470","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1677\/erc.0.0060139","article-title":"The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2","volume":"6","author":"Singh","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdf125_bb0475","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdf125_bb0480","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdf125_bb0485","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1001\/jama.286.8.954","article-title":"Risk of cardiovascular events associated with selective COX-2 inhibitors","volume":"286","author":"Mukherjee","year":"2001","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdf125_bb0490","first-page":"71","article-title":"Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer","volume":"6","author":"Harris","year":"1999","journal-title":"Oncol Rep"},{"key":"10.1093\/annonc\/mdf125_bb0495","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/bmj.299.6710.1247","article-title":"Aspirin use and chronic diseases: a cohort study of the elderly","volume":"299","author":"Paganini-Hill","year":"1989","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdf125_bb0500","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/pmed.1999.0518","article-title":"The relationship of nonsteroidal anti-inflammatory drugs use to the risk of breast cancer","volume":"29","author":"Coogan","year":"1999","journal-title":"Prev Med"},{"key":"10.1093\/annonc\/mdf125_bb0505","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","article-title":"Nested case\u2013control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage","volume":"83","author":"Sharpe","year":"2000","journal-title":"Br J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419628875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/13\/5\/669\/530637\/mdf125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T18:14:52Z","timestamp":1621275292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419628875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["S0923753419628875"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdf125","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}